3rd Quarter - Report

TIBER CREEK GROUP for EMD SERONO, INC.

Firm
Client
Income
$50,000
Expenses
—

What was lobbied

3 issue areas, each in the filer's own words, with who lobbied on it and where.

Health Issues HCR

Issues relating to In Vitro Fertilization (IVF); S. 4348 - Food and Drug Administration Safety and Landmark Advancements Act of 2022; HR 7667 - Food and Drug Amendments of 2022; H.R. 6833 - The Continuing resolution and Ukraine Supplemental Appropriations Act 2023, Division F - FDA User Fee Reauthorization Act of 2022.

LobbyistCovered position, as disclosed
JOHN MICHAEL GONZALEZ —
JONATHON JONES —
COREY MALMGREN —

Contacted: HOUSE OF REPRESENTATIVES; SENATE

Bills named: H.R. 6833 (117th), S. 4348 (117th), H.R. 7667 (117th)

Budget/Appropriations BUD

Issues related to the VA infertility coverage benefit.

LobbyistCovered position, as disclosed
MATTHEW LEFFINGWELL New Chief Counsel, House Energy & Commerce Committee (2015-2022); LD & Senior Policy Counsel, Rep. Rush (2012-2015); House Subcommittee on Commerce, Trade, & Consumer Protection (2009-2012)

Contacted: HOUSE OF REPRESENTATIVES

Medicare/Medicaid MMM

H.R. 5376 - Build Back Better, Subtitle J; Inflation Reduction Act of 2022 (PL 117-169), Subtitle B - Prescription Drug Pricing Reform; Issues relating to Part D pricing reform; issues relating to Medicare Part D and Part B Pricing Reform; Issues related to capping out-of-pocket costs.

LobbyistCovered position, as disclosed
JOHN MICHAEL GONZALEZ —
JONATHON JONES —
COREY MALMGREN —

Contacted: HOUSE OF REPRESENTATIVES; SENATE

Bills named: H.R. 5376 (117th)

Shown as published by the Senate Office of Public Records and the House Clerk under the Lobbying Disclosure Act. The official filing is the record; open it for the full form.